Abstract:Vascular Ehlers-Danlos syndrome or Ehlers-Danlos syndrome type IV (vEDS) is a connective tissue disorder characterised by skin hyperextensibility, joint hypermobility and fatal vascular rupture caused by COL3A1 mutations that affect collagen III expression, homo-trimer assembly and secretion. Along with collagens I, II, V and XI, collagen III plays an important role in the extracellular matrix, particularly in the inner organs. To date, only symptomatic treatment for vEDS patients is available. Fibroblasts derived from vEDS patients carrying dominant negative and/or haploinsufficiency mutations in COL3A1 deposit reduced collagen III in the extracellular matrix. This study explored the potential of an antisense oligonucleotide (ASO)-mediated splice modulating strategy to bypass disease-causing COL3A1 mutations reported in the in-frame exons 10 and 15. Antisense oligonucleotides designed to redirect COL3A1 pre-mRNA processing and excise exons 10 or 15 were transfected into dermal fibroblasts derived from vEDS patients and a healthy control subject. Efficient exon 10 or 15 excision from the mature COL3A1 mRNA was achieved and intracellular collagen III expression was increased after treatment with ASOs; however, collagen III deposition into the extracellular matrix was reduced in patient cells. The region encoded by exon 10 includes a glycosylation site, and exon 15 encodes hydroxyproline and hydroxylysine-containing triplet repeats, predicted to be crucial for collagen III assembly. These results emphasize the importance of post-translational modification for collagen III homo-trimer assembly. In conclusion, while efficient skipping of target COL3A1 exons was achieved, the induced collagen III isoforms generated showed defects in extracellular matrix formation. While therapeutic ASO-mediated exon skipping is not indicated for the patients in this study, the observations are restricted to exons 10 and 15 and may not be applicable to other collagen III in-frame exons.

Identification of a missense mutation of COL3A1 in a Chinese family with atypical Ehlers-Danlos syndrome using targeted next-generation sequencing.

A novel mutation leading to elongation of the deduced α1(X) chain results in Metaphyseal Chondrodysplasia type Schmid.

Ehlers-Danlos Syndrome Type Iv is Associated with A Novel G984r Col3a1 Mutation

Identification of two novel COL3A1 variants in patients with vascular Ehlers-Danlos syndrome

Exome Sequencing Identified Two Novel COL10A1 Heterozygous Mutations in Two Irregular Dominance Chinese Pedigrees with Schmid-type Metaphyseal Chondrodysplasia

Identification of Two Novel COL10A1 Heterozygous Mutations in Two Chinese Pedigrees with Schmid-type Metaphyseal Chondrodysplasia

Two Novel Mutations of COL1A1 in Fetal Genetic Skeletal Dysplasia of Chinese

Importance of comprehensive genetic testing for patients with suspected vascular Ehlers–Danlos syndrome: a family case report and literature review

Identification of a Novel COL4A5 Mutation in a Chinese Family with X-linked Alport Syndrome Using Exome Sequencing.

A Novel<i>COL4A5</i>Mutation Identified in a Chinese Han Family Using Exome Sequencing

377 A Novel Mutation of COL7A1 Was Identified in a Chinese Pedigree of Dystrophic Epidermolysis Bullosa with Next-Generation Sequencing

Functional Assessment of a Novel COL4A5 Splicing Site Variant in a Chinese X-linked Alport Syndrome Family.

[Identification of a Novel Mutation of COL2A1 Gene in a Chinese Family Affected with Spondyloepiphyseal Dysplasia Congenita].

A Novel Heterozygous Mutation of the COL4A3 Gene Causes a Peculiar Phenotype Without Hematuria and Renal Function Impairment in a Chinese Family

A Novel COL4A5 Mutation Identified in a Chinese Han Family Using Exome Sequencing.

Clinical and Molecular Characterization and Discovery of Novel Genetic Mutations of Chinese Patients with COL2A1-related Dysplasia.

A Novel Splicing Mutation Identified in a Chinese Family with X-linked Alport Syndrome Using Targeted Next-Generation Sequencing.

Whole-Exome Sequencing Identified Genes Responsible for Thoracic Aortic Aneurysms and Dissections in Three Chinese Families

Identification of COL3A1 Variants Associated with Sporadic Thoracic Aortic Dissection:A Case-Control Study

Is Exon Skipping a Viable Therapeutic Approach for Vascular Ehlers-Danlos Syndrome with Mutations in COL3A1 Exon 10 or 15?

Study of a Bethlem Myopathy Pedigree Resulted from a Novel Mutation of COL6A3 Gene